Global Female Infertility Epidemiology Forecast to 2028 - ResearchAndMarkets.com

DUBLIN--()--The "Female Infertility: Epidemiology Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

"Female Infertility: Epidemiology Forecast to 2028", provide an overview of the risk factors and global trends of female infertility in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK and Japan).

The report includes a 10-year epidemiological forecast for the total prevalent cases of female infertility segmented by age (for ages 15-44 years) in these markets. The total prevalent cases of female infertility are further segmented by major etiological factors (ovulatory dysfunction disorders, endometriosis, fallopian tube abnormalities, uterine abnormalities, and unexplained etiologies).

The total prevalent cases of female infertility in the seven major markets (US, France, Germany, Italy, Spain, UK, and Japan) combined are expected to decrease from 13.8 million cases in 2018 to 13.4 million cases in 2028, equating to a negative annual growth rate (AGR) of 0.31%. The US is expected to see the highest growth of total prevalent cases of female infertility at a positive AGR of 0.58% during the forecast period, followed by the UK with an AGR of 0.49%. However, the remaining countries - France, Germany, Italy, Spain and Japan - have negative AGRs to 2028.

Infertility is a disease of the reproductive system characterized by the failure to achieve a clinical pregnancy after 12 or more months of regular unprotected sexual intercourse. A considerable proportion of women experience infertility and the inability to bear children is a devastating condition for many couples, bringing a sense of loss, psychological distress, depression, and low self-esteem.

Multiple factors have been identified as possible contributors to fertility problems in women, including socio-demographic, behavioral, physical, and mental health conditions. Some risk factors affecting fertility cannot be changed, while others such as life style choices may be altered. Many of the behavioral factors and health conditions may be preventable, such as smoking, obesity, and diabetes. Although infertility is more prevalent in recent times, the use of advanced assisted reproductive technologies in modern medicine greatly increase the chances of solving infertility problems.

The differences in the trend in total prevalent cases of female infertility across the 7MM is due to the differences in the population trends of females in the reproductive age in the respective markets. In the US and the UK the population of women at reproduction age is increasing whereas in the remaining countries it is decreasing.

Scope

  • The Female Infertility Report provides an overview of the risk factors and global trends of female infertility in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK and Japan).
  • The report includes a 10-year epidemiological forecast for the total prevalent cases of female infertility segmented by age (for ages 15-44 years) in these markets. The total prevalent cases of female infertility are further segmented by major etiological factors (ovulatory dysfunction disorders, endometriosis, fallopian tube abnormalities, uterine abnormalities, and unexplained etiologies).
  • The female infertility epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to Buy

  • Develop business strategies by understanding the trends shaping and driving the global Female Infertility market.
  • Quantify patient populations in the global Female Infertility market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups that present the best opportunities for Female Infertility therapeutics in each of the markets covered.
  • Understand magnitude of Female Infertility population by its etiology.

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Female Infertility: Executive Summary

2.1 Related Reports

2.2 Upcoming Reports

3 Epidemiology

3.1 Disease Background

3.2 Risk Factors and Comorbidities

3.3 Global and Historical Trends

3.4 Forecast Methodology

3.4.1 Sources

3.4.2 Forecast Assumptions and Methods: Total Prevalent Cases of Female Infertility and Impaired Fecundity

3.4.3 Forecast Assumptions and Methods: Total Prevalence of Female Infertility by Major Etiological Factors

3.5 Epidemiological Forecast for Female Infertility and Impaired Fecundity (2018-2028)

3.5.1 Total Prevalent Cases of Female Infertility

3.5.2 Total Prevalent Cases of Impaired Fecundity

3.5.3 Age-Specific Total Prevalent Cases of Female Infertility

3.5.4 Age-Specific Total Prevalent Cases of Impaired Fecundity

3.5.5 Total Prevalent Cases of Female Infertility by Major Etiological Factors

3.6 Discussion

3.6.1 Epidemiological Forecast Insight

3.6.2 Limitations of the Analysis

3.6.3 Strengths of the Analysis

4 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/vsrjdq

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900